Ticker > Company >

Medinova Diagnostic share price

Medinova Diagnostic Services Ltd.

BSE: 526301 SECTOR: Hospital & Healthcare Services  11.65 K   12   0

40.65
-0.06 (-0.15%)
BSE: 02 Sep 04:01 PM

Price Summary

Today's High

₹ 40.71

Today's Low

₹ 40.6

52 Week High

₹ 46.92

52 Week Low

₹ 32.1

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

40.58 Cr.

Enterprise Value

44.69 Cr.

No. of Shares

1 Cr.

P/E

37.6

P/B

0

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  -0.82

CASH

0.88 Cr.

DEBT

5 Cr.

Promoter Holding

62.14 %

EPS (TTM)

₹  1.08

Sales Growth

-3%

ROE

0 %

ROCE

51.29%

Profit Growth

18.16 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-3%
3 Year-13.13%
5 Year6.56%

Profit Growth

1 Year18.16%
3 Year-24.59%
5 Year38.02%

ROE%

1 Year0%
3 Year0%
5 Year0%

ROCE %

1 Year51.29%
3 Year54.56%
5 Year32.74%

Debt/Equity

-4.1792

Price to Cash Flow

29.68

Interest Cover Ratio

3.239

CFO/PAT (5 Yr. Avg.)

1.02805675849995

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 62.14 0.00
Mar 2025 62.14 0.00
Dec 2024 62.14 0.00
Sep 2024 62.14 0.00
Jun 2024 62.14 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROCE of 54.5617666666667% over the past 3 years.
  • The Company has been maintaining an effective average operating margins of 22.2209327770039% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -1661.33 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.02805675849995.
  • The company has a high promoter holding of 62.14%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 10.9294416616237.

 Limitations

  • The company has shown a poor profit growth of -24.5899102467703% for the Past 3 years.
  • The company has shown a poor revenue growth of -13.1292443531045% for the Past 3 years.
  • Company has a poor ROE of 0% over the past 3 years.
  • The company has negative book value.
  • The company is trading at a high PE of 37.6.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 1.86 1.98 1.75 1.97 2.08
Total Expenditure 1.5 1.49 1.39 1.45 1.47
Operating Profit 0.36 0.48 0.36 0.52 0.6
Other Income 0.02 0.02 0.05 0.03 0.03
Interest 0.13 0.13 0.13 0.12 0.12
Depreciation 0.03 0.04 0.04 0.04 0.03
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.22 0.34 0.24 0.39 0.48
Tax 0.05 0.1 0.04 0.11 0.12
Profit After Tax 0.17 0.25 0.2 0.28 0.36
Adjusted EPS (Rs) 0.17 0.25 0.2 0.28 0.36

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 11.32 11.51 7.76 7.78 7.55
Total Expenditure 8.69 8.47 6.28 6.29 5.8
Operating Profit 2.63 3.05 1.48 1.49 1.75
Other Income 0.29 0.22 0.23 0.26 0.12
Interest 0.31 0.45 0.61 0.61 0.53
Depreciation 0.32 0.26 0.24 0.12 0.14
Exceptional Items 0 0 0 0 0
Profit Before Tax 2.29 2.55 0.87 1.02 1.19
Tax 0.13 0.48 0.24 0.26 0.3
Net Profit 2.17 2.07 0.63 0.75 0.89
Adjusted EPS (Rs.) 2.18 2.08 0.63 0.76 0.89

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 9.96 9.96 9.96 9.96 9.96
Total Reserves -15.52 -13.43 -12.79 -12.02 -11.15
Borrowings 3.27 5.75 5.75 5 5
Other N/C liabilities -0.03 -0.29 -0.29 -0.28 -0.2
Current liabilities 6.58 4.09 3.14 2.86 2.63
Total Liabilities 4.26 6.08 5.77 5.51 6.23
Assets
Net Block 0.9 0.8 0.95 1.02 1.32
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 1.27 2.97 2.97 2.97 2.97
Loans & Advances 0.45 0.26 0.28 0.28 0.28
Other N/C Assets 0 0.02 0.09 0.09 0.14
Current Assets 1.64 2.04 1.48 1.15 1.52
Total Assets 4.26 6.08 5.77 5.51 6.23
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 2.29 2.55 0.87 1.02 1.19
Adjustment 0.53 0.53 0.68 0.82 0.64
Changes in Assets & Liabilities -1.35 -1.45 -0.29 -0.23 -0.34
Tax Paid 0.03 -0.5 -0.08 -0.1 -0.12
Operating Cash Flow 1.51 1.13 1.18 1.51 1.37
Investing Cash Flow -0.11 -1.84 -0.34 -0.18 -0.47
Financing Cash Flow -1.15 0.94 -0.78 -1.32 -0.63
Net Cash Flow 0.25 0.24 0.06 0 0.27

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 62.14 62.14 62.14 62.14 62.14
vijaya diagnostic centre ... 62.14 62.14 62.14 62.14 62.14
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 37.86 37.86 37.86 37.86 37.86
duvvuru jalandhar reddy 1.00 1.00 1.00 1.00 1.00
kattamreddy lakshminaraya... 1.25 1.25 1.25 1.25 1.25
muddu krishna reddy oduru... 1.00 1.00 1.00 1.00 1.00
padarthi harinadha reddy 1.25 1.25 1.25 1.25 1.25
rajani vaddi - - 1.92 - 1.18
shankar lal saraf 3.27 3.27 3.27 3.27 3.27
subba lakshmi champati 3.03 3.00 2.98 2.98 2.98

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Medinova Diagnostic Services informs about newspaper publication 12 Aug, 12:41 PM Medinova Diagnostic - Quaterly Results 26 Jul, 12:21 PM Medinova Diagnostic - Quaterly Results 26 Jul, 12:21 PM Medinova Diagnostic - Quaterly Results 26 Jul, 12:21 PM Medinova Diagnostic Services informs about certificate 2 Jul, 5:29 PM Medinova Diagnostic Services informs about newspaper publication 5 May, 10:54 AM Medinova Diagnostic - Quaterly Results 3 May, 4:16 PM Medinova Diagnostic - Quaterly Results 3 May, 4:16 PM Medinova Diagnostic - Quaterly Results 3 May, 4:16 PM Medinova Diagnostic Services submits board meeting intimation 26 Apr, 12:24 PM Medinova Diagnostic Services informs about integrated filing 31 Jan, 9:21 AM Medinova Diagnostic - Quaterly Results 30 Jan, 3:28 PM Medinova Diagnostic - Quaterly Results 30 Jan, 3:28 PM Medinova Diagnostic - Quaterly Results 30 Jan, 3:28 PM Medinova Diagnostic Services informs about compliance certificate 8 Jan, 2:33 PM Medinova Diagnostic - Quaterly Results 29 Oct, 2:04 PM Medinova Diagnostic - Quaterly Results 29 Oct, 2:04 PM Medinova Diagnostic - Quaterly Results 29 Oct, 2:04 PM Medinova Diagnostic Services informs about newspaper publication 31 Jul, 12:20 PM Medinova Diagnostic - Quaterly Results 30 Jul, 12:14 PM Medinova Diagnostic - Quaterly Results 30 Jul, 12:14 PM Medinova Diagnostic - Quaterly Results 30 Jul, 12:14 PM Medinova Diagnostic Services informs about board meeting 23 Jul, 2:24 PM Medinova Diagnostic Services informs about compliance certificate 11 Jul, 12:06 PM Medinova Diagnostic - Quaterly Results 26 Apr, 1:46 PM Medinova Diagnostic - Quaterly Results 26 Apr, 1:46 PM Medinova Diagnostic - Quaterly Results 26 Apr, 1:46 PM Medinova Diagnostic Services informs about certificate 3 Apr, 2:27 PM Medinova Diagnostic Services informs about closure of trading window 22 Mar, 2:42 PM Medinova Diagnostic Services informs about appointment of CFO 31 Jan, 2:58 PM Medinova Diagnostic - Quaterly Results 31 Jan, 12:38 PM Medinova Diagnostic - Quaterly Results 31 Jan, 12:38 PM Medinova Diagnostic - Quaterly Results 31 Jan, 12:38 PM Medinova Diagnostic Services informs about newspaper publication 3 Nov, 4:00 PM Medinova Diagnostic - Quaterly Results 2 Nov, 1:12 PM Medinova Diagnostic - Quaterly Results 2 Nov, 1:12 PM Medinova Diagnostic - Quaterly Results 2 Nov, 1:12 PM Medinova Diagnostic Services submits board meeting intimation 18 Oct, 4:55 PM Medinova Diagnostic - Quaterly Results 28 Jul, 1:45 PM Medinova Diagnostic - Quaterly Results 28 Jul, 1:45 PM Medinova Diagnostic - Quaterly Results 28 Jul, 1:45 PM Medinova Diagnostic - Quaterly Results 17 May, 4:12 PM Medinova Diagnostic - Quaterly Results 17 May, 4:12 PM Medinova Diagnostic - Quaterly Results 17 May, 4:12 PM Medinova Diagnostic - Quaterly Results 1 Feb, 1:22 PM Medinova Diagnostic - Quaterly Results 1 Feb, 1:22 PM Medinova Diagnostic - Quaterly Results 1 Feb, 1:22 PM Medinova Diagnostic - Quaterly Results 2 Nov, 3:25 PM Medinova Diagnostic - Quaterly Results 2 Nov, 3:25 PM Medinova Diagnostic - Quaterly Results 2 Nov, 3:25 PM

Medinova Diagnostic Stock Price Analysis and Quick Research Report. Is Medinova Diagnostic an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Medinova Diagnostic. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Medinova Diagnostic has a PE ratio of 37.6040703052729 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Medinova Diagnostic has ROA of 15.1546% which is a good sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Medinova Diagnostic has a Current ratio of 0.5774.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Medinova Diagnostic has a ROE of 0%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Medinova Diagnostic has a Debt to Equity ratio of -4.1792 which means that the company has low proportion of debt in its capital.

  • Sales growth: Medinova Diagnostic has reported revenue growth of -2.9957% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Medinova Diagnostic for the current financial year is 23.1647699421046%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Medinova Diagnostic is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Medinova Diagnostic is Rs 1.081. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Medinova Diagnostic in Ticker for free. Also, one can get the intrinsic value of Medinova Diagnostic by using Valuation Calculators, which are available with a Finology ONE subscription. 

Medinova Diagnostic FAQs

Q1. What is Medinova Diagnostic share price today?
Ans: The current share price of Medinova Diagnostic is Rs 40.65.

Q2. What is the market capitalisation of Medinova Diagnostic?
Ans: Medinova Diagnostic has a market capitalisation of Rs 40.5753666 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Medinova Diagnostic?
Ans: The PE ratio of Medinova Diagnostic is 37.6040703052729 and the P/B ratio of Medinova Diagnostic is -49.8100722950619, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Medinova Diagnostic share?
Ans: The 52-week high share price of Medinova Diagnostic is Rs 46.92, and the 52-week low share price of Medinova Diagnostic is Rs 32.1.

Q5. Does Medinova Diagnostic pay dividends?
Ans: Currently, Medinova Diagnostic does not pay dividends. Dividend yield of Medinova Diagnostic is around 0%.

Q6. What are the face value and book value of Medinova Diagnostic shares?
Ans: The face value of Medinova Diagnostic shares is Rs 10, while the book value per share of Medinova Diagnostic is around Rs -0.8161. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Medinova Diagnostic?
Ans: Medinova Diagnostic has a total debt of Rs 5 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Medinova Diagnostic?
Ans: The ROE of Medinova Diagnostic is 0% and ROCE of Medinova Diagnostic is 51.2853%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Medinova Diagnostic a good buy for the long term?
Ans: The Medinova Diagnostic long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Medinova Diagnostic undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Medinova Diagnostic appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Medinova Diagnostic’s financials?
Ans: You can review Medinova Diagnostic’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Medinova Diagnostic
X